Skip to main content
Top
Published in: BMC Pediatrics 1/2020

01-12-2020 | Hyperpigmentation | Research article

An evaluation of the clinical features of measles virus infection for diagnosis in children within a limited resources setting

Authors: Dominicus Husada, Kusdwijono, Dwiyanti Puspitasari, Leny Kartina, Parwati Setiono Basuki, Ismoedijanto

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Measles is a recurrent health problem in both advanced and developed countries. The World Health Organization (WHO) recommends anti-measles immunoglobulin M (Ig M) as the standard method of detecting the virus; however, many areas still present the inability to perform a serology test of anti-measles IgM. Therefore, a typical clinical feature is necessary to establish the diagnosis of measles. The objective of this study was to evaluate hyperpigmented rash and other clinical features as the diagnostic tools with respect to measles, especially in an outbreak setting.

Methods

In this observational diagnostic study, the inclusion criteria were as follows: between 6 and 144 months of age, fever, maculopapular rash for 3 days or more, accompanied by a cough, or coryza, or conjunctivitis. Those with a prior history of measles vaccination (1–6 weeks) were excluded, in addition to those with histories of corticosteroid for 2 weeks or more and immunocompromised conditions. The samples were taken from Dr. Soetomo General Academic Hospital in Surabaya, Indonesia. We evaluated the sensitivity, specificity, the positive predictive value, and the negative predictive value of such clinical features. Hyperpigmented rash was validated using Kappa and Mc Nemar tests. Anti-measles Ig M was considered as the gold standard.

Results

This study gathered 82 participants. The clinical manifestations of all subjects included fever, cough, coryza, conjunctivitis, Koplik spots, and maculopapular rash (which turns into hyperpigmented rash along the course of the illness). Most maculopapular rashes turn out to be hyperpigmented (89%). Sensitivity, specificity, positive predictive value, and negative predictive values ​​of the combination of fever, maculopapular rash, and hyperpigmented rash were found to be at 90.7, 28.6, 93.2, and 22.2%, respectively. The Mc Nemar and Kappa tests showed p values of 0.774 and 0.119, respectively.

Conclusion

The combination of fever, maculopapular rash, and hyperpigmented rash can be used as a screening tool regarding measles infection in an outbreak setting, which can then be confirmed by anti-measles Ig M. Cough, coryza, and Koplik’s spot can be added to this combination, albeit with a slight reduction of sensitivity value.
Appendix
Available only for authorised users
Literature
3.
go back to reference Kulkarni RD, Ajantha GS, Kiran AR, Pravinchandra KR. Global eradication of measles: are we poised? Indian J Med Microbiol. 2017;35(1):10–6.CrossRefPubMed Kulkarni RD, Ajantha GS, Kiran AR, Pravinchandra KR. Global eradication of measles: are we poised? Indian J Med Microbiol. 2017;35(1):10–6.CrossRefPubMed
4.
go back to reference Cherry JD, Lugo D. Measles virus. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia: Elsevier; 2019. p. 1754–70. Cherry JD, Lugo D. Measles virus. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia: Elsevier; 2019. p. 1754–70.
5.
go back to reference Maldonado IA, Shetty AK. Rubeola virus: measles and subacute sclerosing panencephalitis. In: Long SS, Prober CG, Fischer M, editors. Principles and practice of pediatric infectious diseases. 5th ed. Philadelphia: Elsevier; 2018. p. 1169–75.CrossRef Maldonado IA, Shetty AK. Rubeola virus: measles and subacute sclerosing panencephalitis. In: Long SS, Prober CG, Fischer M, editors. Principles and practice of pediatric infectious diseases. 5th ed. Philadelphia: Elsevier; 2018. p. 1169–75.CrossRef
7.
go back to reference Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL. Progress towards regional measles elimination worldwide, 2000-2014. Wkly Epidemiol Rec. 2015;90:623–31. Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL. Progress towards regional measles elimination worldwide, 2000-2014. Wkly Epidemiol Rec. 2015;90:623–31.
9.
go back to reference Kumar DJ, Sabella C. Measles: back again. Cleveland Clin J Med. 2016;83(5):340–4.CrossRef Kumar DJ, Sabella C. Measles: back again. Cleveland Clin J Med. 2016;83(5):340–4.CrossRef
10.
go back to reference Europen Centre for Disease Prevention and Control. Monthly measles and rubella monitoring report – October 2019. Stockholm: ECDC; 2019. Europen Centre for Disease Prevention and Control. Monthly measles and rubella monitoring report – October 2019. Stockholm: ECDC; 2019.
11.
go back to reference Cherry JD. Cutaneous manifestations of systemic infections. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia: Elsevier; 2019. p. 539–58. Cherry JD. Cutaneous manifestations of systemic infections. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia: Elsevier; 2019. p. 539–58.
12.
go back to reference Sarkar RR, Mishra K, Garg VK. Fever with rash in a child in India. Indian J Dermatol Venereol Leprol. 2012;78(3):251–62.CrossRefPubMed Sarkar RR, Mishra K, Garg VK. Fever with rash in a child in India. Indian J Dermatol Venereol Leprol. 2012;78(3):251–62.CrossRefPubMed
15.
go back to reference Katz SL. Measles (Rubeola). In: Gershon AA, Hotez PJ, Katz SL, editors. Krugman's infectious diseases of children. 11th ed. Philadelphia: Mosby; 2004. p. 353–71. Katz SL. Measles (Rubeola). In: Gershon AA, Hotez PJ, Katz SL, editors. Krugman's infectious diseases of children. 11th ed. Philadelphia: Mosby; 2004. p. 353–71.
16.
go back to reference Leung AKC, Hon KL, Leong KF, Sergi CM. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018;24:512–20.PubMed Leung AKC, Hon KL, Leong KF, Sergi CM. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018;24:512–20.PubMed
18.
go back to reference Akiyoshi K, Suga T, Nukuzuma S, Kon-no M, Shibata M, Itoh M, Ito M, Ihara T. Reevaluation of laboratory methods for diagnosis of measles. J Infect Dis. 2010;63:225–8. Akiyoshi K, Suga T, Nukuzuma S, Kon-no M, Shibata M, Itoh M, Ito M, Ihara T. Reevaluation of laboratory methods for diagnosis of measles. J Infect Dis. 2010;63:225–8.
19.
go back to reference Nouanthong P, Hubschen JM, Billamay S, Mongkhoune S, Vilivong K, Khounvisith V, Sinner R, Grandadam M, Phonekeo D, Black AP, Muller CP. Varicella zoster and fever rash surveillance in Lao People’s Democratic Republic. BMC Infect Dis. 2019;19:392.CrossRefPubMedPubMedCentral Nouanthong P, Hubschen JM, Billamay S, Mongkhoune S, Vilivong K, Khounvisith V, Sinner R, Grandadam M, Phonekeo D, Black AP, Muller CP. Varicella zoster and fever rash surveillance in Lao People’s Democratic Republic. BMC Infect Dis. 2019;19:392.CrossRefPubMedPubMedCentral
20.
go back to reference Njim T, Aminde LN, Feteh FV, Ngum JM, Moustapha CA. Measles outbreak in a poorly vaccinated region in Cameroon: a case series study, public health challenges and recommendations. Pan African Med J. 2015;22:163.CrossRef Njim T, Aminde LN, Feteh FV, Ngum JM, Moustapha CA. Measles outbreak in a poorly vaccinated region in Cameroon: a case series study, public health challenges and recommendations. Pan African Med J. 2015;22:163.CrossRef
21.
go back to reference Olugbade OT, Adeyemi AS, Adeoti AH, Ilesanmi OS, Gidado SO, Waziri NE, Aworh MK. Measles outbreaks and supplemental immunization activities (SIA): the Gwagwalada experience, Abuja 2015. Pan African Med J. 2019;32(Supp1):10. Olugbade OT, Adeyemi AS, Adeoti AH, Ilesanmi OS, Gidado SO, Waziri NE, Aworh MK. Measles outbreaks and supplemental immunization activities (SIA): the Gwagwalada experience, Abuja 2015. Pan African Med J. 2019;32(Supp1):10.
22.
go back to reference Lee CT, Hagan JE, Jantsansengee B, Tumurbataar OE, Altanchimeg A, Yadamsuren B, Demberelsuren S, Tserendori C, Munkhtogoo O, Badarch D, Gunregjav N, Baatarkhuu B, Ochir C, Berman L, Anderson R, Patel MK, Gregory CJ, Goodson JL. Increase in infant measles deaths during a nationwide measles outbreak – Mongolia, 2015-2016. J Infect Dis. 2019. https://doi.org/10.1093/infdis/jiz140. Lee CT, Hagan JE, Jantsansengee B, Tumurbataar OE, Altanchimeg A, Yadamsuren B, Demberelsuren S, Tserendori C, Munkhtogoo O, Badarch D, Gunregjav N, Baatarkhuu B, Ochir C, Berman L, Anderson R, Patel MK, Gregory CJ, Goodson JL. Increase in infant measles deaths during a nationwide measles outbreak – Mongolia, 2015-2016. J Infect Dis. 2019. https://​doi.​org/​10.​1093/​infdis/​jiz140.
23.
go back to reference Estivariz CF, Watkins MA, Handoko D, Rusipah R, Deshpande J, Rana BJ, Irawan E, Widhiastuti D, Pallansch MA, Thapa A, Imari S. A large vaccine-derived poliovirus outbreak on Madura Island, Indonesia, 2005. J Infect Dis. 2008;197(3):347–54.CrossRefPubMed Estivariz CF, Watkins MA, Handoko D, Rusipah R, Deshpande J, Rana BJ, Irawan E, Widhiastuti D, Pallansch MA, Thapa A, Imari S. A large vaccine-derived poliovirus outbreak on Madura Island, Indonesia, 2005. J Infect Dis. 2008;197(3):347–54.CrossRefPubMed
24.
go back to reference Hughes GJ, Mikhail AF, Husada D, Irawan E, Kafatos G, Bracebridge S, Pebody R, Efstratiou A. Seroprevalence and determinants of immunity to diphtheria for children living in two districts of contrasting incidence during an outbreak in East Java, Indonesia. Pediatr Infect Dis J. 2015;34(11):1152–6.CrossRefPubMed Hughes GJ, Mikhail AF, Husada D, Irawan E, Kafatos G, Bracebridge S, Pebody R, Efstratiou A. Seroprevalence and determinants of immunity to diphtheria for children living in two districts of contrasting incidence during an outbreak in East Java, Indonesia. Pediatr Infect Dis J. 2015;34(11):1152–6.CrossRefPubMed
25.
go back to reference Hartoyo E, Wiyatno A, Jaya UA, Ma’roef CN, Monagin C, Myint KS, Safari D. Occurence of measles genotype D8 during a 2014 outbreak in Banjarmasin, South Kalimantan,. Indonesia. Int J Infect Dis. 2017;54:1–3.CrossRefPubMed Hartoyo E, Wiyatno A, Jaya UA, Ma’roef CN, Monagin C, Myint KS, Safari D. Occurence of measles genotype D8 during a 2014 outbreak in Banjarmasin, South Kalimantan,. Indonesia. Int J Infect Dis. 2017;54:1–3.CrossRefPubMed
26.
go back to reference Pronyk P, Sugihandono A, Sitohang V, Moran T, Kadandale S, Muller S, Whetham C, Kezaala R. Vaccine hesitancy in Indonesia. Lancet. 2019;3:e114. Pronyk P, Sugihandono A, Sitohang V, Moran T, Kadandale S, Muller S, Whetham C, Kezaala R. Vaccine hesitancy in Indonesia. Lancet. 2019;3:e114.
29.
go back to reference Getahun M, Beyene B, Ademe A, Teshome B, Telera M, Asha A, Afework A, HaileMariyam Y, Asefa E, Gallagher K. Epidemiology of laboratory confirmed measles virus cases in Amhara regional state of Ethiopia, 2004-2014. BMC Infect Dis. 2016;16:133.CrossRefPubMedPubMedCentral Getahun M, Beyene B, Ademe A, Teshome B, Telera M, Asha A, Afework A, HaileMariyam Y, Asefa E, Gallagher K. Epidemiology of laboratory confirmed measles virus cases in Amhara regional state of Ethiopia, 2004-2014. BMC Infect Dis. 2016;16:133.CrossRefPubMedPubMedCentral
31.
go back to reference Sengkeopraseuth B, Khamphaphongphane B, Vongphrachanh P, Xeuatvongsa A, Norasingh S, Pathammvong C, Phengxay M, Philakong P, Datta SS. Analysing the characteristics of measles outbreak in Houaphanh province to guide measles elimination in the Lao People’s Democratic Republic. WPSAR. 2018;9(3). https://doi.org/10.5365/wpsar.2018.8.1.012. Sengkeopraseuth B, Khamphaphongphane B, Vongphrachanh P, Xeuatvongsa A, Norasingh S, Pathammvong C, Phengxay M, Philakong P, Datta SS. Analysing the characteristics of measles outbreak in Houaphanh province to guide measles elimination in the Lao People’s Democratic Republic. WPSAR. 2018;9(3). https://​doi.​org/​10.​5365/​wpsar.​2018.​8.​1.​012.
32.
go back to reference Primadi O, Zulfi, Pangribowo S, Susanti MI, Rois AS, Prihantoro B. Profil Kesehatan Indonesia Tahun 2014. Jakarta, Kementerian Kesehatan Republik Indonesia 2015. Primadi O, Zulfi, Pangribowo S, Susanti MI, Rois AS, Prihantoro B. Profil Kesehatan Indonesia Tahun 2014. Jakarta, Kementerian Kesehatan Republik Indonesia 2015.
33.
go back to reference Thapa A, Khanal S, Sharapov U, Swezy V, Sedai T, Dabbagh A, Rota P, Goodson JL, McFarland J. Progress toward measles elimination-South East Asia region, 2003-2013. MMWR. 2015;64(22):613–7.PubMedPubMedCentral Thapa A, Khanal S, Sharapov U, Swezy V, Sedai T, Dabbagh A, Rota P, Goodson JL, McFarland J. Progress toward measles elimination-South East Asia region, 2003-2013. MMWR. 2015;64(22):613–7.PubMedPubMedCentral
34.
go back to reference Morbidity Mortality Weekly Report. Classification of measles cases and categorization of measles elimination program. Morb Mortal Wkly Rep. 1983;31:707–11. Morbidity Mortality Weekly Report. Classification of measles cases and categorization of measles elimination program. Morb Mortal Wkly Rep. 1983;31:707–11.
35.
go back to reference Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(Suppl1):S4–16.PubMed Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189(Suppl1):S4–16.PubMed
36.
go back to reference Mayo DR, Brennan T, Cormier DP, Hadler J, Lamb P. Evaluation of commercial measles virus immunoglobulin enzyme immunoassay. J Clin Microbiol. 1992;29(12):2865–7.CrossRef Mayo DR, Brennan T, Cormier DP, Hadler J, Lamb P. Evaluation of commercial measles virus immunoglobulin enzyme immunoassay. J Clin Microbiol. 1992;29(12):2865–7.CrossRef
37.
go back to reference Ozanne G, Halewyn MA. Performance and reliability of the enzygnost measles enzyme-linked immunosorbent assay for detection measles virus-specific immunoglobulin M antibody during a large measles epidemic. J Clin Microbiol. 1992;30(3):564–9.CrossRefPubMedPubMedCentral Ozanne G, Halewyn MA. Performance and reliability of the enzygnost measles enzyme-linked immunosorbent assay for detection measles virus-specific immunoglobulin M antibody during a large measles epidemic. J Clin Microbiol. 1992;30(3):564–9.CrossRefPubMedPubMedCentral
38.
go back to reference World Health Organization. In: 2, editor. Manual for laboratory diagnosis of measles and rubella virus infection. Geneva: WHO-Department of Immunization, Vaccine, and Biologicals; 2007. World Health Organization. In: 2, editor. Manual for laboratory diagnosis of measles and rubella virus infection. Geneva: WHO-Department of Immunization, Vaccine, and Biologicals; 2007.
39.
go back to reference Hutchins SS, Papania MJ, Amler R, Maes EF, Grabowsky M, Bromberg K, Glasgow V, Speed T, Bellini J, Orenstein WA. Evaluation of the measles clinical case definition. J Infect Dis. 2004;189(Suppl 1):S153–9.PubMed Hutchins SS, Papania MJ, Amler R, Maes EF, Grabowsky M, Bromberg K, Glasgow V, Speed T, Bellini J, Orenstein WA. Evaluation of the measles clinical case definition. J Infect Dis. 2004;189(Suppl 1):S153–9.PubMed
40.
41.
go back to reference Tannous LK, Barlow G, Metcalfe NH. A short clinical review of vaccination against measles. J R Soc Med Open. 2014;5(4):1–6. Tannous LK, Barlow G, Metcalfe NH. A short clinical review of vaccination against measles. J R Soc Med Open. 2014;5(4):1–6.
42.
go back to reference Ramsay M, Reacher M, O’Flynn C, Buttery R, Hadden F, Cohen B, Knowles W, Wreghitt T, Brown D. Causes of morbiliform rash in a highly immunised English population. Arch Dis Child. 2002;87:202–6.CrossRefPubMedPubMedCentral Ramsay M, Reacher M, O’Flynn C, Buttery R, Hadden F, Cohen B, Knowles W, Wreghitt T, Brown D. Causes of morbiliform rash in a highly immunised English population. Arch Dis Child. 2002;87:202–6.CrossRefPubMedPubMedCentral
43.
go back to reference Barbosa JR, Martins AS, Ruivo J, Carvalho L. Fever and rash: revisiting measles. Acta Medica Port. 2018;31(6):341–5.CrossRef Barbosa JR, Martins AS, Ruivo J, Carvalho L. Fever and rash: revisiting measles. Acta Medica Port. 2018;31(6):341–5.CrossRef
44.
go back to reference Patel AB. Postinflammatory hyperpigmentation: review of pathogenesis, prevention, and treatment. Pigment Int. 2014;1(2):59–66.CrossRef Patel AB. Postinflammatory hyperpigmentation: review of pathogenesis, prevention, and treatment. Pigment Int. 2014;1(2):59–66.CrossRef
45.
go back to reference Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis, and treatment. Am J Dermatol. 2018;19(4):489–503.CrossRef Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis, and treatment. Am J Dermatol. 2018;19(4):489–503.CrossRef
47.
go back to reference Borras-Blasco J, Navarro-Ruiz A, Borras C, Castera E. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. J Antimicrob Chemother. 2008;62:879–88.CrossRefPubMed Borras-Blasco J, Navarro-Ruiz A, Borras C, Castera E. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection. J Antimicrob Chemother. 2008;62:879–88.CrossRefPubMed
48.
go back to reference Garcia RMG, Molina SC. Drug-induced hyperpigmentation: review and case series. J Am Board Fam Med. 2019;32:628–38.CrossRef Garcia RMG, Molina SC. Drug-induced hyperpigmentation: review and case series. J Am Board Fam Med. 2019;32:628–38.CrossRef
49.
go back to reference Tsilika K, Tran A, Trucchi R, Pop S, Anty R, Cardot-Leccia N, Lacour JP, Ortonne JP, Passeron T. Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis virus C infection. J Am Med Assoc Dermatol. 2013;149:675–7. Tsilika K, Tran A, Trucchi R, Pop S, Anty R, Cardot-Leccia N, Lacour JP, Ortonne JP, Passeron T. Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis virus C infection. J Am Med Assoc Dermatol. 2013;149:675–7.
50.
go back to reference Zheng G, Cao L, Che Z, Mao E, Chen E, He J. Polymixin B-induced skin hyperpigmentation: a rare case report and literature review. BMC Pharmacol Ther. 2018;19:41.CrossRef Zheng G, Cao L, Che Z, Mao E, Chen E, He J. Polymixin B-induced skin hyperpigmentation: a rare case report and literature review. BMC Pharmacol Ther. 2018;19:41.CrossRef
51.
go back to reference Lee MS, Nokes DJ, Hsu HM, Lu CF. Protective titers of measles neutralizing antibody. J Med Virol. 2000;62:511–7.CrossRefPubMed Lee MS, Nokes DJ, Hsu HM, Lu CF. Protective titers of measles neutralizing antibody. J Med Virol. 2000;62:511–7.CrossRefPubMed
52.
go back to reference Hubschen JM, Bork SM, Brown KE, Mankertz A, Santibanez S, Mamou MB, Mulders MN, Muller CP. Challenge of measles and reubella laboratory diagnostic in the era of elimination. Clin Microbiol Inf. 2017;23:511–5.CrossRef Hubschen JM, Bork SM, Brown KE, Mankertz A, Santibanez S, Mamou MB, Mulders MN, Muller CP. Challenge of measles and reubella laboratory diagnostic in the era of elimination. Clin Microbiol Inf. 2017;23:511–5.CrossRef
53.
go back to reference Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis. 2003;187(Suppl 1):S283–90.CrossRefPubMed Bellini WJ, Helfand RF. The challenges and strategies for laboratory diagnosis of measles in an international setting. J Infect Dis. 2003;187(Suppl 1):S283–90.CrossRefPubMed
55.
go back to reference Cutts FT. Measles. Geneva, WHO. 1996:1–20. Cutts FT. Measles. Geneva, WHO. 1996:1–20.
56.
go back to reference Chan WM, Lee SY, Kwan YW, Chow CB, Leung CW. Modified clinical manifestations of measles in young infants:10 years’ experience in a tertiary referral center of Hong Kong. HongKong J Paediatr. 2010;15:1226–31. Chan WM, Lee SY, Kwan YW, Chow CB, Leung CW. Modified clinical manifestations of measles in young infants:10 years’ experience in a tertiary referral center of Hong Kong. HongKong J Paediatr. 2010;15:1226–31.
57.
go back to reference Ciccone FH, Carvalhanas TRMP, Afonso AMS, Flannery B, Waldman EA. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, state of Sao Paulo, Brazil, 2000-2004. Rev Soc Bras Med Trop. 2010;43(3):234–9.CrossRefPubMed Ciccone FH, Carvalhanas TRMP, Afonso AMS, Flannery B, Waldman EA. Investigation of measles IgM-seropositive cases of febrile rash illnesses in the absence of documented measles virus transmission, state of Sao Paulo, Brazil, 2000-2004. Rev Soc Bras Med Trop. 2010;43(3):234–9.CrossRefPubMed
58.
go back to reference Griffin DE. Measles virus. In: Dm K, Howley P, editors. Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. Griffin DE. Measles virus. In: Dm K, Howley P, editors. Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
60.
go back to reference Riddell MA, Moss WJ, Hauer D, Monze M, Griffin D. Slow clearance of measles virus RNA after acute infection. J Clin Virol. 2007;39:312–7.CrossRefPubMed Riddell MA, Moss WJ, Hauer D, Monze M, Griffin D. Slow clearance of measles virus RNA after acute infection. J Clin Virol. 2007;39:312–7.CrossRefPubMed
62.
go back to reference Zenner D, Nacul L. Predictive power of Koplik’s spots for the diagnosis of measles. J Infect Dev Ctries. 2012;6(3):271–5.CrossRefPubMed Zenner D, Nacul L. Predictive power of Koplik’s spots for the diagnosis of measles. J Infect Dev Ctries. 2012;6(3):271–5.CrossRefPubMed
63.
go back to reference Zhang Y, Yu YS, Zhang GQ. Maculopapular rash and Koplik’s spot in adult measles. Rev Soc Bras Med Trop. 2015;48(2):231.CrossRefPubMed Zhang Y, Yu YS, Zhang GQ. Maculopapular rash and Koplik’s spot in adult measles. Rev Soc Bras Med Trop. 2015;48(2):231.CrossRefPubMed
65.
go back to reference Ely JW, Stone MS. The generalized rash: part II. Diaggnostic approach. Am Fam Physician. 2010;81(6):735–9.PubMed Ely JW, Stone MS. The generalized rash: part II. Diaggnostic approach. Am Fam Physician. 2010;81(6):735–9.PubMed
67.
go back to reference Davis EC, Callender VD. Postinflammatory hyperpigmentation. J Clin Aesthetic Dermatol. 2010;3(7):20–31. Davis EC, Callender VD. Postinflammatory hyperpigmentation. J Clin Aesthetic Dermatol. 2010;3(7):20–31.
68.
go back to reference Piot P, Larson HJ, O’Brien KL, N’kengasong J, Ng E, Sow S, Kampmann B. Immunization: vital progress, unfinished agenda. Nature. 2019;575:119–29.CrossRefPubMed Piot P, Larson HJ, O’Brien KL, N’kengasong J, Ng E, Sow S, Kampmann B. Immunization: vital progress, unfinished agenda. Nature. 2019;575:119–29.CrossRefPubMed
Metadata
Title
An evaluation of the clinical features of measles virus infection for diagnosis in children within a limited resources setting
Authors
Dominicus Husada
Kusdwijono
Dwiyanti Puspitasari
Leny Kartina
Parwati Setiono Basuki
Ismoedijanto
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-1908-6

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue